DE602006017217D1 - Stereoselektives hydrierverfahren zur herstellung von cis-6-phenyl-5-ä4-(2-pyrrolidin-1-yl-ethoxy)-phenylü-2-methoxy-5,6,7,8-tetrahydronaphthalin-hydrochlorid - Google Patents

Stereoselektives hydrierverfahren zur herstellung von cis-6-phenyl-5-ä4-(2-pyrrolidin-1-yl-ethoxy)-phenylü-2-methoxy-5,6,7,8-tetrahydronaphthalin-hydrochlorid

Info

Publication number
DE602006017217D1
DE602006017217D1 DE602006017217T DE602006017217T DE602006017217D1 DE 602006017217 D1 DE602006017217 D1 DE 602006017217D1 DE 602006017217 T DE602006017217 T DE 602006017217T DE 602006017217 T DE602006017217 T DE 602006017217T DE 602006017217 D1 DE602006017217 D1 DE 602006017217D1
Authority
DE
Germany
Prior art keywords
phenyl
pyrrolidin
ethoxy
cis
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017217T
Other languages
English (en)
Inventor
Richard Shelton Lehner
Geraldine P Taber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE602006017217D1 publication Critical patent/DE602006017217D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006017217T 2005-06-22 2006-06-12 Stereoselektives hydrierverfahren zur herstellung von cis-6-phenyl-5-ä4-(2-pyrrolidin-1-yl-ethoxy)-phenylü-2-methoxy-5,6,7,8-tetrahydronaphthalin-hydrochlorid Active DE602006017217D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69288205P 2005-06-22 2005-06-22
PCT/IB2006/001773 WO2006136944A1 (en) 2005-06-22 2006-06-12 Stereoselective hydrogenation process for preparing cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-2-methoxy-5,6,7,8-tetrahydronaphthalene hydrochloride

Publications (1)

Publication Number Publication Date
DE602006017217D1 true DE602006017217D1 (de) 2010-11-11

Family

ID=37057316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017217T Active DE602006017217D1 (de) 2005-06-22 2006-06-12 Stereoselektives hydrierverfahren zur herstellung von cis-6-phenyl-5-ä4-(2-pyrrolidin-1-yl-ethoxy)-phenylü-2-methoxy-5,6,7,8-tetrahydronaphthalin-hydrochlorid

Country Status (8)

Country Link
US (1) US20100160648A1 (de)
EP (1) EP1899310B1 (de)
JP (1) JP2009501143A (de)
AT (1) ATE482940T1 (de)
CA (1) CA2611035C (de)
DE (1) DE602006017217D1 (de)
ES (1) ES2350853T3 (de)
WO (1) WO2006136944A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011146610A2 (en) * 2010-05-19 2011-11-24 Dr. Reddy's Laboratories Ltd. An enantioselective synthesis of chiral amines for the production of rotigotine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522319A (en) * 1964-01-23 1970-07-28 Ciba Geigy Corp Phenol substituted tetrahydronaphthalenes useful as estrogenics
US5117013A (en) * 1990-05-03 1992-05-26 Eastman Kodak Company Process for the selective hydrogenation γ, δ-epoxyalkenes to epoxyalkanes
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
EE200200580A (et) * 2000-04-07 2004-06-15 Pfizer Products Inc. Östrogeeni agonisti/antagonisti metaboliidid

Also Published As

Publication number Publication date
JP2009501143A (ja) 2009-01-15
EP1899310B1 (de) 2010-09-29
ATE482940T1 (de) 2010-10-15
CA2611035C (en) 2010-09-14
CA2611035A1 (en) 2006-12-28
EP1899310A1 (de) 2008-03-19
ES2350853T3 (es) 2011-01-27
US20100160648A1 (en) 2010-06-24
WO2006136944A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
DE602006021645D1 (de) Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten
ATE540009T1 (de) Verfahren zur herstellung von ethylen
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
DE602005015174D1 (de) Verfahren zur herstellung von montelukast-natrium
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
ATE500221T1 (de) Verfahren zur herstellung von hydroisoindolin- tachykinin-rezeptorantagonisten
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
ATE457356T1 (de) Verfahren zur herstellung von vorwiegend ein enantiomer enthaltendes 1,1,1-trifluorisopropanol
DE602004014264D1 (de) Verfahren zur herstellung von olanzapin
DE602006017217D1 (de) Stereoselektives hydrierverfahren zur herstellung von cis-6-phenyl-5-ä4-(2-pyrrolidin-1-yl-ethoxy)-phenylü-2-methoxy-5,6,7,8-tetrahydronaphthalin-hydrochlorid
ATE427306T1 (de) Verfahren zur herstellung von escitalopram
DE50310200D1 (de) Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE602005016857D1 (de) Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten
DE60318444D1 (de) Verfahren zur herstellung von nevirapin
FR2854402B1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
ATE469137T1 (de) Racematspaltung von 2,6-trans-dimethylmorpholin
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
DE502005003019D1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
ATE550422T1 (de) Verfahren zur herstellung von mycophenolsäure mit penicillium arenicola bicc7673
UA91153C2 (ru) Способ получения формы и венлафаксина гидрохлорида
DE502006005580D1 (de) Verfahren zur herstellung von optisch aktiven 3-phenylpropionsäurederivaten und folgeprodukte davon